Anticoagulation and Long-Haul Travel: What Patients on Warfarin, DOACs and Heparin Need to Know Before They Fly

Long-distance air travel is a recognised risk factor for venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), the so-called ‘economy class syndrome,’ though the risk is not confined to economy seating. For the general healthy traveller, the absolute risk from a single long-haul flight is low. For patients at Halton Pharmacy in Leeds who are already anticoagulated, the clinical picture is more nuanced: anticoagulation does substantially reduce the additional VTE risk from prolonged immobility, but it introduces its own management challenges for travel.

VTE Risk and Long-Haul Flights

Prolonged immobility in a seated position reduces venous return from the lower limbs, causing venous stasis that promotes thrombus formation in the deep veins of the calf. Cabin altitude (equivalent to approximately 1,800 to 2,400 metres) causes mild dehydration and borderline hypoxia, further increasing prothrombotic tendency. The absolute risk of symptomatic DVT from a single long-haul flight in a low-risk individual is approximately 1 in 6,000 rising substantially in individuals with additional risk factors: previous VTE, known thrombophilia, active malignancy, recent surgery, pregnancy, and use of oestrogen-containing contraception.

Patients who are already therapeutically anticoagulated (for atrial fibrillation, previous VTE, mechanical heart valves, or other indications) are partially protected against the additional VTE risk of flight. However, anticoagulation introduces practical management challenges that warrant a pre-travel clinical review.

Warfarin: The Specific Challenges of Travel

Warfarin requires regular INR monitoring to ensure therapeutic anticoagulation, and travel disrupts this in several ways. Diet changes abroad, altered mealtimes, gastrointestinal illness, alcohol consumption, and changes in physical activity all affect INR stability. Some destinations are also significantly warmer or drier than the UK, increasing fluid requirements and potentially affecting drug absorption.

Patients on warfarin travelling for more than two to four weeks should ideally have an INR checked shortly before departure and discuss the appropriate monitoring plan for the duration of their trip with their anticoagulation service. In some destinations, INR testing facilities are available through local medical services; in others, access may be limited. Self-testing INR devices (CoaguChek) may be an option for patients who travel frequently and are trained in self-monitoring.

DOACs: More Travel-Friendly, But Not Without Considerations

Direct oral anticoagulants (DOACs), including apixaban, rivaroxaban, edoxaban, and dabigatran, do not require INR monitoring and are generally more travel-friendly than warfarin from a management perspective. However, several DOAC-specific considerations apply:

• • Time zone changes and dose timing: rivaroxaban is twice daily during the first 3 week treatment for VTE otherwise is once daily and apixaban is twice-daily preparations for some indications; a prescriber or pharmacist should advise on dose adjustment for significant time zone shifts to maintain appropriate dosing intervals

• • Supply: DOACs are not universally available in all countries, and obtaining an equivalent product abroad is not straightforward. Carrying an adequate supply for the full trip, plus a surplus, is essential

• • Drug interactions: antibiotics commonly prescribed for travel-related infections (including some fluoroquinolones and macrolides) can affect DOAC levels. This should be discussed as part of the travel health consultation for any anticoagulated patient

Compression Stockings: Still Relevant for Anticoagulated Patients

Graduated compression stockings (15-30mmHg) are recommended for long-haul flights in patients at elevated VTE risk and remain appropriate even for anticoagulated patients, as they address the mechanical component of venous stasis that anticoagulation alone does not fully mitigate. Additional physical measures, regular walking in the cabin where safe, calf exercises in the seat, and adequate hydration are standard recommendations for all long-haul travellers.

This article is for general information and does not constitute individual clinical advice. Please book a consultation at Halton Pharmacy in Leeds to discuss anticoagulation management and travel health planning.